XML 192 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Revenue      
Total revenue $ 23,353,185 $ 17,757,283 $ 9,378,673
Cost of finished cannabis inventory sold (11,155,676) (9,227,439) (3,997,617)
Cost of service revenues (308,641) (154,353)
Gross profit, excluding fair value items 11,888,868 8,529,844 5,226,703
Realized fair value amounts in inventory sold (2,573,151) (3,685,338) (950,461)
Unrealized fair value gain on growth of biological assets 3,355,797 3,278,572 1,824,226
Gross profit 12,671,514 8,123,078 6,100,468
Expenses      
Accretion expense 1,026,732 491,781 949,811
Amortization of property and equipment 578,641 750,916 180,015
General and administrative 6,465,877 5,852,236 3,983,250
Share-based compensation 346,113 70,996 280,819
Total expenses 8,417,363 7,165,929 5,398,892
Income from operations 4,254,151 957,149 701,576
Other income and (expense)      
Interest expense (370,616) (402,239) (197,632)
Other income (expense) 441,487 (3,432) (17,072)
Gain on debt settlement 453,858 141,180
Loss on settlement of non-controlling interest (189,816)
Unrealized loss on marketable securities (333,777) (35,902)
Unrealized loss on derivative liability (4,563,498) (1,258,996)
Unrealized gain on warrants asset 129,113
Loss on disposal of property and equipment (182,025) (6,250) (7,542)
Total other expense, net (4,545,539) (291,840) (1,565,780)
Income (loss) from operations before taxes (291,388) 665,309 (864,204)
Income tax (Note 20) (370,932) (245,358) (150,543)
Net income (loss) (662,320) 419,951 (1,014,747)
Other comprehensive income (items that may be subsequently reclassified to profit and loss):      
Currency translation (4,562) (19,235) (78,181)
Total comprehensive income (loss) $ (666,882) $ 400,716 $ (1,092,928)
Gain (loss) per share attributable to shareholders – basic and diluted $ (0.00) $ 0.00 $ (0.02)
Weighted average shares outstanding – basic and diluted 172,708,792 169,193,812 135,231,802
Net income (loss) for the year attributable to:      
Non-controlling interest $ (129,279) $ (27,507) $ 1,395,558
Shareholders (533,041) 447,458 (2,410,305)
Comprehensive income (loss) for the year attributable to:      
Shareholders (537,603) 428,223 (2,488,486)
Products [Member]      
Revenue      
Total revenue 22,424,169 17,757,283 9,034,618
Services [Member]      
Revenue      
Total revenue $ 929,016 $ 344,055